The advent of computer graphic processing units, improvement in mathematical models and
availability of big data has allowed artificial intelligence (AI) using machine learning (ML) …

The targeting of vascular endothelial growth factor A (VEGFA), a crucial regulator of both
normal and pathological angiogenesis, has revealed innovative therapeutic approaches in …

Background Numerous population-based studies of age-related macular degeneration have
been reported around the world, with the results of some studies suggesting racial or ethnic …

Background: Age-related macular degeneration is a leading cause of severe, irreversible
vision impairment in developed countries. The primary risk factors for the development of …

Purpose To determine efficacy and safety of intravitreal aflibercept in patients with
neovascular age-related macular degeneration (AMD) during a second year of variable …

This meta-analysis reports on current estimates of the prevalence of age-related macular
degeneration (AMD) based on a review of recent meta-analyses and literature research …

As the age of the population increases in many nations, age‐related degenerative diseases
pose significant socioeconomic challenges. One of the key degenerative diseases that …

PURPOSE: To report incidence rates of legal blindness from age-related macular
degeneration (AMD) and other causes in Denmark from years 2000 to 2010 in the age …

BACKGROUND AND OBJECTIVE: To investigate the potential of ultrahigh-speed swept-
source optical coherence tomography angiography (OCTA) to visualize retinal and choroidal …

Background Systematically review the evidence describing the impact of anti–vascular
endothelial growth factor (anti-VEGF) therapy on neovascular age-related macular …